A chicken monoclonal antibody with specificity for the N-terminal of human prion protein

被引:43
|
作者
Matsuda, H
Mitsuda, H
Nakamura, N
Furusawa, S
Mohri, S
Kitamoto, T
机构
[1] Hiroshima Univ, Fac Appl Biol Sci, Dept Immunobiol, Higashihiroshima, Hiroshima 7398528, Japan
[2] Kyushu Univ, Fac Med, Biomed Res Ctr, Fukuoka 8128582, Japan
[3] Tohoku Univ, Sch Med, Dept Neurol Sci, Aoba Ku, Sendai, Miyagi 9808575, Japan
来源
关键词
chicken monoclonal antibody; prion protein; Creutzfeldt-Jakob disease; Gerstmann-Straussler syndrome;
D O I
10.1016/S0928-8244(98)00135-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Chickens were immunized with human prion protein (PrP) peptide H25 (amino acid residues 25-49) coupled to keyhole limpet hemocyanin. From a fusion experiment using the chicken fusion partner cell line MuH1 and immune spleen cells, one mAb, HUC2-13, was generated which reacted with the peptide. HUC2-13 was specific for a pentapeptide (RPKPG) of the N-terminal of the peptide H25. Tn Western blotting analysis, the mAb reacted with PrP materials from a human Creutzfeldt-Jakob disease (CJD) case and the membrane fraction from normal murine brain,but not with the same materials pretreated with proteinase K. When compared with the HUC2-13 and the conventional mouse mAb 3F4, the background stainings using the HUC2-13 were minimal. In immunohistochemistry, the HUC2-13 stained positively with kuru plaques in brain sections from patients with Gerstmann-Straussler syndrome (GSS), and also reacted with synaptic structures of the CJD patients. However, any immunolabelings using the HUC2-13 were not observed in the section from a patient with amyotrophic lateral sclerosis (ALS) as CJD-negative control. These results indicate that the mAb HUC2-13 is a suitable tool for immunological and diagnostic analyses of prion disease in humans and other mammals. (C) 1999 Federation of European Microbiological Societies. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:189 / 194
页数:6
相关论文
共 50 条
  • [21] Amyloid fibrils from the N-terminal prion protein fragment are infectious
    Choi, Jin-Kyu
    Cali, Ignazio
    Surewicz, Krystyna
    Kong, Qingzhong
    Gambetti, Pierluigi
    Surewicz, Witold K.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (48) : 13851 - 13856
  • [22] SPECIFICITY DETERMINANTS FOR N-TERMINAL ACETYLATION AND REMOVAL OF N-TERMINAL ACETYLMETHIONINE
    WOLD, F
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1987, : 242 - 242
  • [23] PRINT: A Protein Bioconjugation Method with Exquisite N-terminal Specificity
    Surojit Sur
    Yuan Qiao
    Anja Fries
    Robert N. O’Meally
    Robert N. Cole
    Kenneth W. Kinzler
    Bert Vogelstein
    Shibin Zhou
    Scientific Reports, 5
  • [24] PRINT: A protein bioconjugation method with exquisite N-terminal specificity
    Sur, Surojit
    Qiao, Yuan
    Fries, Anja C.
    O'Meally, Robert N.
    Cole, Robert N.
    Kinzler, Kenneth W.
    Vogelstein, Bert
    Zhou, Shibin
    CANCER RESEARCH, 2016, 76
  • [25] PRINT: A Protein Bioconjugation Method with Exquisite N-terminal Specificity
    Sur, Surojit
    Qiao, Yuan
    Fries, Anja
    O'Meally, Robert N.
    Cole, Robert N.
    Kinzler, Kenneth W.
    Vogelstein, Bert
    Zhou, Shibin
    SCIENTIFIC REPORTS, 2015, 5
  • [26] Role of N-terminal familial mutations in prion protein fibrillization and prion amyloid propagation in vitro
    Jones, EM
    Surewicz, K
    Surewicz, WK
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (12) : 8190 - 8196
  • [27] A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike protein
    Chen, Yingzhu
    Lu, Shuai
    Jia, Hao
    Deng, Yao
    Zhou, Jianfang
    Huang, Baoying
    Yu, Yueyang
    Lan, Jiaming
    Wang, Wenling
    Lou, Yongliang
    Qin, Kun
    Tan, Wenjie
    EMERGING MICROBES & INFECTIONS, 2017, 6
  • [28] The N-terminal tandem repeat region of human prion protein reduces copper: Role of tryptophan residues
    Ruiz, FH
    Silva, E
    Inestrosa, NC
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 269 (02) : 491 - 495
  • [29] MONOCLONAL-ANTIBODIES TO THE N-TERMINAL REGION OF HUMAN ERYTHROPOIETIN
    EGRIE, J
    HYBRIDOMA, 1983, 2 (01): : 136 - 136
  • [30] N-terminal or Signal Peptide Sequence Engineering Prevents Truncation of Human Monoclonal Antibody Light Chains
    Gibson, S. J.
    Bond, N. J.
    Milne, S.
    Lewis, A.
    Sheriff, A.
    Pettman, G.
    Pradhan, R.
    Higazi, D. R.
    Hatton, D.
    BIOTECHNOLOGY AND BIOENGINEERING, 2017, 114 (09) : 1970 - 1977